Market Analysts Maintain Buy Rating on Xylem, Lower Multiple Targets

Multiple Wall Street firms maintained Buy ratings on Xylem after the water technology company reported Q1 2026 results on April 28, though several lowered price targets citing a cautious full-year outlook. Stifel cut its target to $163 from $175 while holding its Buy rating. Oppenheimer maintained its Buy with a $158 target, and JPMorgan trimmed its target to $160 from $170. UBS was the outlier with a more bearish stance, carrying a $132 target after downgrading to Hold in late April.

XYL reported Q1 EPS of $1.12, beating the $1.09 consensus estimate, and revenue of $2.125 billion, slightly ahead of the $2.11 billion estimate. However, the company's full-year 2026 EPS guidance of $5.35–$5.60 came in below some analyst models, prompting the target reductions despite the in-quarter beat. Shares dipped on the cautious forward guidance even as the company raised its dividend.

Of 23 analysts currently covering Xylem, 14 maintain Buy ratings and 9 carry Hold ratings — a constructive consensus that reflects confidence in XYL's exposure to water infrastructure spending and its recurring revenue base from smart water meters and analytics. The key debate is whether the full-year guidance is conservative or reflects genuine demand moderation, with the answer likely hinging on municipal utility spending trends in H2 2026.